Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV crossover comparison of MultiHance vs Dotarem for brain MRI
2013-003886-33Phase 4Completed
- Sponsor
- Bracco Imaging
- Start
- Dec 2013
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of gadobenate dimeglumine in brain neoplasm (2 arms), sponsored by Bracco Imaging. Primary endpoint: Global diagnostic preference. Started Dec 2013; status: completed.
02
Drugs
gadobenate dimeglumine
03
Conditions
brain neoplasm
Beyond the preview
Go deeper on 2013-003886-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003886-33.